We are live on ! Find out more
CELGZ

Celgene Corporation Contingent Value Rights

Delisted

CELGZ was delisted on the 29th of November, 2019.

20 hedge funds and large institutions have $654K invested in Celgene Corporation Contingent Value Rights in 2019 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

91% more capital invested

Capital invested by funds: $343K → $654K (+$311K)

5% less funds holding

Funds holding: 2120 (-1)

67% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 6

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
20
Holders Change
-1
Holders Change %
-4.76%
% of All Funds
0.43%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
2
Reduced
6
Closed
1
Calls
Puts
Net Calls
Net Calls Change

CELGZ Hedge Fund Activity: Q1 2019 in Review

20 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Celgene Corporation Contingent Value Rights (CELGZ) for Q1 2019, worth a combined $654K — up 91% from $343K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of CELGZ and 0 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 2 added.

The largest buyer was Citadel Advisors, adding an estimated $52.8K. The largest seller was FCG Advisors, cutting an estimated $51.1K.

  • 20 institutional investors held Celgene Corporation Contingent Value Rights (CELGZ) as of Q1 2019, down from 21 in Q4 2018.
  • Funds reported $654K of Celgene Corporation Contingent Value Rights stock for Q1 2019, up 91% quarter-over-quarter.
  • 0 funds opened new Celgene Corporation Contingent Value Rights positions in Q1 2019 and 1 closed out, a net change of -1 holder.
  • The largest Celgene Corporation Contingent Value Rights buyer in Q1 2019 was Citadel Advisors, an estimated $52.8K added.
  • The largest Celgene Corporation Contingent Value Rights seller in Q1 2019 was FCG Advisors, an estimated $51.1K sold.

Based on aggregated 13F filings for Q1 2019.